|
|
||||||||
Ann Thorac Surg 1998;65:144-148
© 1998 The Society of Thoracic Surgeons
Cardiac Transplantation Research Laboratory, Division of Cardiothoracic Surgery, Columbia-Presbyterian Medical Center, New York, New York, USA
Accepted for publication July 15, 1997.
Background. The synthetic peptide corresponding to residues 75-84 of the human major histocompatibility complex class I molecule HLA-B7 (Allotrap 07) has been shown to inhibit differentiation of cytotoxic T lymphocyte precursors. Subsequent treatment of LEW-1A rats with this peptide was associated with a reduction in the level of cytotoxic activity directed to donor alloantigens. This study was undertaken to investigate the effect of Allotrap 07 on rodent heart allograft survival in LEW-1A recipients.
Methods. Heart allografts from Lewis rats were heterotopically transplanted into the infrarenal abdominal aorta of ACI recipients. The treatment groups consisted of different regimens of short-term intravenous Allotrap 07 and oral cyclosporin A. All grafts were palpated daily, with rejection defined as the cessation of palpable contractions.
Results. Cardiac allografts transplanted from Lewis to ACI rats survived indefinitely after administration of intravenous Allotrap 07 and oral cyclosporin A. Tolerance induction was donor-specific because third-party Brown-Norway, but not Lewis, grafts were rapidly rejected after implantation into ACI recipients.
Conclusions. Because donor-specific tolerance persisted long after cessation of peptide administration and did not occur when cyclosporin A was omitted from the immunosuppressive regimen, the mechanism may involve induction of clonal anergy.
This article has been cited by other articles:
![]() |
K. Kishimoto, X. Yuan, H. Auchincloss Jr., A. H. Sharpe, D. A. Mandelbrot, and M. H. Sayegh Mechanism of Action of Donor-Specific Transfusion in Inducing Tolerance: Role of Donor MHC Molecules, Donor Co-stimulatory Molecules, and Indirect Antigen Presentation J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2423 - 2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Ng, M. Hernandez-Fuentes, R. Baker, A. Chaudhry, and R. I. Lechler Reversibility with Interleukin-2 Suggests that T Cell Anergy Contributes to Donor-Specific Hyporesponsiveness in Renal Transplant Patients J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2983 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. MAGEE, H. AZUMA, A. KNOFLACH, M. D. DENTON, A. CHANDRAKER, S. IYER, R. BUELOW, and M. SAYEGH In Vitro and in Vivo Immunomodulatory Effects of RDP1258, a Novel Synthetic Peptide J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1997 - 2005. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |